Innvocept and PAR Clinical Join Forces to Offer Global Solutions

Strategic Collaboration to Enhance Clinical Drug Development

Boston, Massachusetts – October 15, 2024 – Innvocept Global Solutions LLC, USA and PAR Clinical , USA announced a strategic collaboration today, uniting their expertise in clinical drug development and technology solutions. This partnership will expand both companies' global capabilities and provide innovative, integrated solutions for the healthcare and life sciences sectors.

Our collaboration with PAR Clinical strengthens Innvocept Global Solutions' ability to deliver seamless, end-to-end clinical research services in USA. With PAR Clinical's expertise in clinical trials and Innvocept’s global operational capabilities, we are uniquely positioned to provide innovative, cost-effective solutions that accelerate time to market for life-saving therapies. This partnership reflects our shared commitment to quality, compliance, and the advancement of healthcare solutions worldwide. We are pleased to announce that Siddharth will spearhead strategic business opportunities for Innvocept in the US and other international markets as a strategic business consultant. His expertise will be invaluable as we expand our global reach, ensuring that Innvocept’s services are accessible wherever our clients need support. Siddharth’s leadership will further strengthen our commitment to providing comprehensive and customized solutions worldwide." — Dr. Manish Rajak , CEO and Co-founder of Innvocept Global Solutions .

We are excited to announce our collaboration with Innvocept Solutions. Our relationship with Innvocept Solutions has evolved and having worked with them over the years we see great value that we can bring to our clients with this collaboration. At PAR Clinical we are focused on growing organically, ensuring that we are adequately resourced to support our client needs. As we evolve in our journey, we must collaborate with the right partners to expand our offerings to our clients. We have the foundational elements to support early-stage drug development companies, and with this collaboration, we will be expanding our reach globally utilizing Innvocept Solution’s operational strengths and their innovative technology platforms to continue providing value to our clients.?We look forward to building this relationship further." — Siddharth Parulkar , CEO and Founder of PAR Clinical .

Key Highlights of the Collaboration

• Expanded Global Reach: Combining PAR Clinical's expertise in clinical trials with Innvocept's global operational capabilities will enable seamless, end-to-end clinical research services worldwide.
• Innovative Solutions: The partnership will leverage Innvocept's technological prowess, including CTMS, EDC, RTSM, ePRO, and PV systems, to streamline drug development processes and accelerate timelines.
• Enhanced Efficiency: By integrating their strengths, the companies aim to provide cost-effective solutions that improve the efficiency of clinical trials and accelerate time to market for life-saving therapies.
• Strategic Leadership: Siddharth will spearhead strategic business opportunities for Innvocept in the US and other international markets, ensuring accessibility to Innvocept's services wherever clients require support.

About PAR Clinical

PAR Clinical is an emerging strategic knowledge research organization specializing in advising early-stage drug development companies. They offer comprehensive solutions that accelerate the development of novel therapies, helping companies transition from bench to bed and de-risking assets as they mature.

Learn more about us at www.parclinical.com.

About Innvocept Global Solutions

Innvocept Global Solutions is a leading provider of comprehensive services and technology solutions for the healthcare and life sciences sectors. They support all phases of clinical research, from early discovery to post-market studies, focusing on Real-World Evidence (RWE), clinical operations, and data-driven insights.

Learn more about us at www.innvocept.com.

Looking Ahead

This collaboration marks a significant step towards advancing healthcare solutions worldwide. Both companies are committed to providing innovative, efficient, and compliant solutions to meet the growing demands of the industry.